article · BMC Infectious Diseases

Helicobacter pylori eradication rates using clarithromycin and levofloxacin-based regimens in patients with previous COVID-19 treatment: a randomized clinical trial

Ahmed Kamal
Aliaa Ismail
Ramy Mohamed Ghazy
Dalia Sherief
Walid Ismail Ellakany

202320 citationsOpen accessKafr el-Sheikh University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Helicobacter pylori-related gastroenterology studies
Gastrointestinal disorders and treatments
Clostridium difficile and Clostridium perfringens research

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1186/s12879-023-07993-8

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.